![R. Elsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
R. Elsey
Direktor/Vorstandsmitglied bei
REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: 1 691 $ am 30.09.2026
Profil
Mr. R.
D.
Elsey is an Independent Non-Executive Director at BullFrog AI Holdings, Inc., a Treasurer & Director at Cancer Support Community and an Independent Director at RegeneRx Biopharmaceuticals, Inc. He is on the Board of Directors at BullFrog AI Holdings, Inc., Cancer Support Community, RegeneRx Biopharmaceuticals, Inc. and Learning Undefeated, Inc. Mr. Elsey was previously employed as a Chief Financial Officer, Secretary & Treasurer by Lyra Therapeutics, Inc., an Independent Director by OpGen, Inc., a Chief Financial Officer, Secretary & Treasurer by Senseonics Holdings, Inc., a Chief Financial Officer by Senseonics, Inc., a Chief Financial Officer & Senior Vice President by Regado Biosciences, Inc., a Chief Financial Officer by LifeCell Corp., a CFO, Treasurer, SVP-Finance & Administration by Emergent BioSolutions, Inc., a Director-Finance & Administration by BioVeris Corp., a Director-Finance & Administration by IGEN International, Inc., and a Finance Director by Applera Corp.
He received his undergraduate degree from Michigan State University and an MBA from Michigan State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 2 813 ( 0,02 % ) | 1 691 $ | 30.09.2026 |
Aktive Positionen von R. Elsey
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.09.2010 |
| BULLFROG AI HOLDINGS, INC. | Direktor/Vorstandsmitglied | 14.02.2023 |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | 12.01.2010 |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Direktor/Vorstandsmitglied | 01.01.2012 |
Ehemalige bekannte Positionen von R. Elsey
| Unternehmen | Position | Ende |
|---|---|---|
| CAPFORCE INC. | Direktor/Vorstandsmitglied | 25.03.2024 |
| LYRA THERAPEUTICS, INC. | Finanzdirektor/CFO | 13.09.2021 |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Finanzdirektor/CFO | 01.02.2019 |
| SENSEONICS HOLDINGS, INC. | Finanzdirektor/CFO | 07.01.2019 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Finanzdirektor/CFO | 06.02.2015 |
Ausbildung von R. Elsey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
RegeneRx Biopharmaceuticals, Inc.
 RegeneRx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets novel therapeutic peptide for tissue and organ protection, repair & regeneration | Health Technology |
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Senseonics Holdings, Inc.
 Senseonics Holdings, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Commercial Services |
BullFrog AI Holdings, Inc.
 BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
